Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Bioverse Tirzepatide Review: Cost, a Genuine Brand Pathway & Honest Verdict (2026)

An honest 2026 review of Bioverse tirzepatide — a wide compounded-and-brand formulary, no hidden fees, and thin accreditation disclosure.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

FDA warning letter
FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025 (Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)). Read the letter on FDA’s own warning-letter database.

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

bmiMD

Flat-priced compounded tirzepatide at every dose — but the advertised rate is a twelve-month prepay, not a monthly one.

$179/mo flat ($139 on 12-mo prepay)

Check bmiMD availability

Bioverse: it genuinely stocks brand-name Ozempic, Wegovy, and Mounjaro alongside compounded semaglutide and tirzepatide and metformin — a wider formulary than most compounded-only competitors — but doesn't display a LegitScript seal or PCAB accreditation anywhere on the site. Every fact here comes from the company's own published program.

What Bioverse is

Bioverse (GoBioverse) is a broader longevity telehealth platform, also covering NAD+, B12, glutathione, hair, skincare, and heart health rather than specializing in weight loss alone. An online intake is reviewed by a licensed clinician before prescribing.

§ Bioverse — Formulary and Accreditation

ItemStatus
FormularyCompounded + brand Ozempic, Wegovy, Mounjaro, metformin —
Tirzepatide price~$399/mo starting dose
AccreditationNo LegitScript or PCAB seal found
Verified: brand and compounded formulary breadth. Not found on the site: LegitScript or PCAB accreditation seals.

What Bioverse costs

Compounded tirzepatide starts around $399/month at the starting dose. This review's live pass confirmed the formulary breadth (Ozempic, Wegovy, Mounjaro, and metformin all appear on the site) but could not independently reconfirm the specific dollar figure, since Bioverse does not publish pricing until after the intake — confirm current pricing directly before committing.

A genuinely wide formulary

Bioverse's site references Ozempic, Wegovy, Mounjaro, and metformin by name alongside its compounded semaglutide and tirzepatide offerings — a real, checkable breadth most single-track compounded sellers don't match. It also advertises no membership, cancellation, doctor, or hidden fees.

The brand-vs-compounded question

Bioverse offers both compounded and genuine brand-name GLP-1 medications — a real choice if brand access matters to you. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; brand tirzepatide (Zepbound/Mounjaro) is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Bioverse's real strengths: a genuinely wide formulary spanning both compounded and brand-name GLP-1s plus metformin, no membership, cancellation, doctor, or hidden fees, and a stated use of US-licensed, FDA-regulated pharmacies. The trade-offs: this review found no visible LegitScript or PCAB accreditation anywhere on the site, state availability isn't disclosed beyond "a provider licensed in your state," and the platform's broader longevity focus means weight loss is one offering among many rather than the specialty. As with any GLP-1 program, ask directly about accreditation and your state's coverage before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Bioverse's formulary breadth — genuine brand-name access alongside compounded options — is a real strength, but the absence of any visible LegitScript or PCAB accreditation is worth asking about directly before committing. If accreditation matters more to you, compare it against Alternate Health Club or BetterMe Rx, both LegitScript verified. For a provider whose advertised rate this review found genuinely impossible to confirm before completing a medical intake, see Bliv. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Bioverse?

Around $399/month at the starting dose. Bioverse does not publish pricing until after the intake, so confirm current figures directly.

Does Bioverse offer brand-name tirzepatide?

Yes — Ozempic, Wegovy, and Mounjaro are all referenced by name alongside the compounded options.

Is Bioverse LegitScript accredited?

This review found no visible LegitScript or PCAB accreditation seal anywhere on the site.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.